No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Instruments & Supplies
JTEC Corporation specializes in the full spectrum of automation systems, from their initial development and design to manufacturing and ultimate sale. The company's activities are divided into two core segments: Optical Business and the Development of Automatic Systems for Life-Science Devices. The Optical Business unit is responsible for producing and supplying highly precise X-ray mirrors, which are utilized across various industries such as pharmaceutical research, electronics, materials science, food production, and cosmetics. Meanwhile, the Automated Systems for Life-Science Devices division engineers and produces automated equipment and integrated systems. These solutions serve a broad range of sectors, including pharmaceuticals, semiconductors, chemistry, printing, color recognition, image processing, and software development. Founded by Takashi Tsumura on December 21, 1993, JTEC Corporation's corporate headquarters are located in Ibaraki, Japan.
www.j-tec.co.jpNo one on the platform currently holds 3446.T.
No tracked institution reports a position in 3446.T as of their last filing.
No one on the platform has traded 3446.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 1.8% | — | — | — | ||
| Rev. Growth % | 1.6% | 19.0% | ||||
| Profit Margin % | 3.0% | 5.2% | 6.6% | |||
| Free Cash Flow Margin % | -2.5% | 5.0% | -5.2% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $2.9B | +19.1% | $60.60 | $60.60–$60.60 | — | 1 |
| 2028 | $3.6B | +26.1% | $95.30 | $95.30–$95.30 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 3446.TJTEC Corporation | $1609.00 | -0.31% | $9.5B | — |
| 3628.TData Horizon Corporation | $669.00 | -0.15% | $8.5B | — |
| 4524.TMorishita Jintan Co., Ltd. | $2246.00 | +0.36% | $9.2B | — |
| 4583.TChiome Bioscience Inc. | $88.00 | +1.15% | $6.4B | — |
| 4597.TSolasia Pharma K.K. | $29.00 | +0.00% | $7.9B | — |
| 4890.TTsubota Laboratory Incorporated | $268.00 | +4.28% | $6.9B |
Source: Financial Modeling Prep · peers by sector/industry
| — |
| 5187.TCreate Medic Co., Ltd. | $1142.00 | +0.09% | $9.3B | — |